December, 11th, 2015 – Atlanta, Georgia – Howard Leonhardt will present the BioLeonhardt Myostim stem cell pump + bioelectric stimulator for heart regeneration at the 2015 World Stem Cell Summit in Atlanta December 12th 11:30am to 12:30pm at Hyatt Regency, 265 Peachtree St NE, Atlanta, GA – Grand Hall East A-B RegMed Company Presentations Session 23-26

The BioLeonhardt MyoStim pump+stimulator is implanted in a patients abdomen.  The micro pump is re-filled once a week with a cardio myogenic cocktail of stem cells, growth factors, micro RNAs and nutrient hydrogel.  The pump contents are infused slowly into the damaged area of the heart over time via an infustion pacing lead.  The bioelectric stimualtor causes controlled release of SDF-1, VEGF, Follistatin and Hepatocyte Growth Factor and controls the differention of cells into contractile muscle and mature blood vessels within heart scar tissue.  The current translation studies are designed to prove out ability to fully regenerate a damaged heart over a 36 month course of treatment.   SDF-1 is a stem cell homing factor, VEGF grows blood vessels, Follistatin grows muscle and Hepatocyte Growth Factor prevents arrhythmias. 

Leonhardt Ventures, the parent of BioLeonhardt MyoStim, and its team of collaborating research scientists have been studying stem cell based regeneration of hearts since 1988 and has helped raise and put to work over $100 million to date for developing heart, cardiovascular and other organ regeneration and healing products. 

BioLeonhardt MyoStim is being incubated in the Leonhardt Ventures’ Cal-X Stars Business Accelerator, Inc in Santa Monica and Santa Rosa, California. 

BioLeonhardt, Leonhardt Ventures’ and the Cal-X Stars Business Accelerator are led by a team over 70 proven industry veterans- and over 35 leading scientists –

Leonhardt Ventures Portfolio technologies include… 

MyoStim Pacers – http:/ – heart failure pacemaker designed to recruit reparative stem cells to damaged and weakened heart tissue. 

MyoStim Microcurrent Stimulators – Full lineup of microcurrent stimulators for stem cell directed organ regeneration and healing – 

Bioheart, Inc. – – Phase III leader in applying adult muscle stem cells to treat advanced heart failure since 1999. In the Phase II/III MARVEL randomized, double blinded, placebo controlled study Bioheart’s MyoCell achieved 95.7 meters improvement in exercise capacity over placebo (minus 4 meters). The MARVEL study included 33 leading U.S. heart failure centers. 

BioPace – biological pacemaker made entirely of living cells – 

Cardiobridge – – high flow rate 10FR circulatory support catheter pump in clinical testing for acute decompensating heart failure and high-risk PCI. Relieving the heart of work load is being studied to possibly improve stem cell transplantation results.

Valvublator – heart valve regeneration with stem cell based bioelecric stimulation – +

AortaCell – Bioelectric stimulation stem cell based aorta regeneration –

DentaCell – Stem cell repair of damaged teeth gums with bioelectric stimulation- 

CerebreCell – Bioelectric stimulation and stem cell infusion for brain regeneration –

EyeCell – Bioelectric stimulation and stem cell infusion for eye regeneration  –

Stem Cell Bra – – the world’s first women’s bra designed to recruit her own stem cells with a homing signal and to build new breast tissue without surgery – patent pending. Clinical safety and efficacy test results pending. 

HeartScore – – precision medicine, functional genomics and tech monitoring platform for reducing hospitalizations from heart failure. 

PancreaCell – pancreas regeneration via micropump + bioelectric stimulation combination device. 

RegenaLung – lung regeneration via micropump + biolelectric stimulation combination device.

MyoStim ED – stem cell and bioelectric stimulation treatment of erectile dysfunction. 

MyoStim Skin – skin regeneration via bioelectric stimulation and stem cell based microcurrent dressings. 

Tisugen Therapeutics – joint healing and regeneration and arthritis treatment with electric acupuncture and stem cells (this startup is in the UNIC STIC Incubator in Santa Rosa, CA see where Leonhardt serves on the board). 

BioLeonhardt MyoStim has begun to develop and file patent applications for a FULL BODY REGENERATION CHAMBER utilizing wireless energy to scan and direct regenerative energy signals (recruits stem cells) to organs in need of regeneartion including brain, skin, eyes, liver, kidney, pancreas, heart, joints.

About The 2015 World Stem Cell Summit — (WSCS 15) – -being held at Hyatt Regency in Atlanta, Georgia is an engine for discovery, funding and commercialization. Planned by and for the stem cell and regenerative medicine community, the Summit brings global stakeholders together to solve global challenges. The goal of the summit is to accelerate the discovery and development of lifesaving cures and therapies. The summit builds a foundation to advance cell therapies by establishing a supportive environment of regulation, legislation, financing, reimbursement and patient advocacy. 

About Leonhardt Ventures: Since 1982 Leonhardt Ventures has a strong history of inventing, developing, backing and bringing to market leadership products for treating heart and cardiovascular disease. Over 240,000 patients have been treated to date with Leonhardt inventions. Leonhardt Venture’s started the Cal-X Stars Business Accelerator in 2012 to guide forward cardiovascular and social good impact innovations over a 5 year period. 

About Howard Leonhardt: Inventor with over 21 patents for treating cardiovascular disease. Serial entrepreneur founding over 30 startups. 1980’s led development of turn key cardiac cath labs, cardiovascular balloon catheters, drug and radiation delivery catheters and intravascular lung. 1990’s developed and patented leading endovascular stent graft and percutaneous heart valve systems. Stent graft captured 70% world market share for repairing thoracic aortic aneurysms without surgery. Developed and patented first stem cell delivery catheter – ProCell. 2000’s – launched first clincial trials for stem cell repair of damaged hearts. Developed and patented biological pacemaker. Introduced first cardiovascular genetic test on U.S. market. 2010’s – Developed and patented full lineup of bioelectric stimulation devices for directing stem cell regeneration and repair of damaged organs and for improving blood flow and healing. Developed first implantable, programmable, re-fillable stem cell pump + electrical stimulator combination devices for organ regeneration. Developed patent pending first Stem Cell Bra. Serves as co-leader and state spokesperson for Startup California for The JOBS ACT and Crowdfunding. Chairman of The California Stock Exchange TM  Founder of The Kindheart Lionheart INSPIRATIONAL WORKS TV Network Serves on the board of the Cell Therapy Foundation – and numerous other boards including UCLA Bioengineering, USC Center for Technology & Innovation Pediatric, University of Northern California Science & Technology Innovation Center and the University of Florida Center for Entrepreneurship and Innovation since 2000. He is testing the waters for a 2018 run for the Lt. Governor’s office in California which appoints 5 of the 12 board members for the California Institute of Regenerative Medicine (CIRM).   He and his son Ryan have produced Leonhardt Vineyards wines in California since 2005 

About Cal-X Crowdfund Connect Helping life science firms build fund raising campaigns working with approved high quality portals and service providers – What we do CLICK HERE – 

Contact: Howard Leonhardt, Leonhardt Ventures’ Cal-X Stars Business Accelerator, Inc., 1531 6th Street, Unit 401, Santa Monica, California, 90401, Office direct 310 310 2534, Email 

SOURCE Leonhardt Ventures